INTEGRATION OF LABORATORY DATA IN PREDICTING THE EPIDEMIOLOGY OF DIABETES
Keywords:
diabetes mellitus, epidemiology, laboratory diagnostics, biomarkers, HbA1c, prognosis, risk stratification.Abstract
Diabetes mellitus is one of the most pressing global public health challenges, with its prevalence steadily increasing worldwide. Early detection, assessment of disease risk, and population-level prediction are essential for developing effective preventive strategies. The aim of this study is to evaluate the role of integrating laboratory data in predicting the epidemiology of diabetes mellitus. The results demonstrate that the comprehensive analysis of biomarkers such as glucose, HbA1c, insulin, lipid profile, C-reactive protein, and other indicators enables high-accuracy prediction of diabetes risk. An integrated laboratory model contributes to improving both individual and population-level risk stratification.
References
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2023;46(Suppl 1):S1-S291.
IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021.
WHO. Global report on diabetes. Geneva: World Health Organization; 2023.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment. Diabetologia. 1985;28:412-419.
DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787-835.
Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein and risk of diabetes. JAMA. 2001;286:327-334.
Pickup JC. Inflammation and activated innate immunity in T2DM. Diabetes Care. 2004;27:813-823.
Усманова, У. И., & Муминов, Ж. З. (2023). РОЛЬ КЛЕТОЧНОГО ИММУНИТЕТА ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ ИШЕМИЧЕСКОЙ ЭТИОЛОГИИ. Экономика и социум, (6-1 (109)), 1107-1110.
Усманова, У. И., & Муминов, Ж. З. (2023). ПАТОГЕНЕТИЧЕСКОЕ ВЛИЯНИЕ ЦИТОКИНОВ НА ПРОГРЕССИРОВАНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ ИШЕМИЧЕСКОЙ ЭТИОЛОГИИ. Экономика и социум, (3-1 (106)), 520-523.
Усманова, У. И., & Муминов, Ж. З. (2023). ХАРАКТЕРИСТИКА АУТОИММУННЫХ ПРОЦЕССОВ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ ИШЕМИЧЕСКОЙ ЭТИОЛОГИИ. Re-health journal, (1-1 (17)), 95-97.






Azerbaijan
Türkiye
Uzbekistan
Kazakhstan
Turkmenistan
Kyrgyzstan
Republic of Korea
Japan
India
United States of America
Kosovo